Tcg Crossover Management, LLC Portfolio Holdings

Tcg Crossover Management, LLC

  • $490 Million
  • Q2 2025

Tcg Crossover Management, LLC has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $490 Million distributed in 38 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Tango Therapeutics, Inc. with a value of $55M, Cogent Biosciences, Inc. with a value of $50M, Ocular Therapeutix, Inc with a value of $49.4M, Amylyx Pharmaceuticals, Inc. with a value of $38.1M, and Centessa Pharmaceuticals PLC with a value of $38M.

Examining the 13F form we can see an increase of $75.3M in the current position value, from $415M to 490M.

Tcg Crossover Management, LLC is based out at Palo Alto, CA

Below you can find more details about Tcg Crossover Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $490 Million
Healthcare: $490 Million

Stock Holdings Table Market Cap. of $200 Billions or more

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 38
  • Current Value $490 Million
  • Prior Value $415 Million
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 6 stocks
  • Additional Purchases 1 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track Tcg Crossover Management, LLC Portfolio

Follow Tcg Crossover Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tcg Crossover Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tcg Crossover Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email